rosiglitazone has been researched along with Cardiomegaly in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, L; Liu, Y; Liu, YH; Wang, NP; Zhang, X; Zhao, BL | 1 |
| Al Yacoub, N; Awad, SM; El-Orabi, NF; Kunhi, M; Pharaon, LF; Poizat, C | 1 |
| Fang, L; Liu, Y; Mao, G; Tang, H; Wang, N; Yan, X; Zhao, B | 1 |
| Chang, CS; Chen, JY; Ho, LC; Maeda, N; Pandya, K; Sung, JM; Tsai, PJ; Tsai, YS | 1 |
| Kelder, T; Kleemann, R; Kooistra, T; Radonjic, M; Salic, K; van Ommen, B; Verschuren, L; Wielinga, PY | 1 |
| Chen, J; Dalton, ND; Fang, L; Fang, X; Gu, Y; Huang, HD; Ouyang, K; Peterson, KL; Stroud, MJ; Wang, N; Wu, T; Zhang, J | 1 |
| Bao, Y; Cai, B; Chen, S; Gao, J; Jiang, J; Le, K; Li, R; Liu, P; Zhang, F | 1 |
| Achouba, A; Arsenault, M; Brûlé, S; Couet, J; Deshaies, Y; Festuccia, WT; Guerra-Sá, R; Houde, VP; Lachance, D; Laplante, M; Marette, A; Pedrosa, ML; Silva, ME | 1 |
| Hu, D; Li, Y; Liu, N; Ren, L; Sheng, Z; Tang, R | 1 |
| Chen, YT; Cheng, JT; Chi, TC; Lee, HH; Lo, SH; Yeh, CH | 1 |
| Ai, D; Guan, YF; Li, N; Niu, XL; Pang, W; Zhu, Y | 1 |
| Cherian-Shaw, M; Hammock, BD; Hye Khan, MA; Imig, JD; Nagasawa, T; Shaw, SM; Walsh, KA | 1 |
| Amiri, F; Diep, QN; Iglarz, M; Paradis, P; Schiffrin, EL; Touyz, RM; Viel, EC | 1 |
| Duan, SZ; Ivashchenko, CY; Milstone, DS; Mortensen, RM; Russell, MW | 1 |
| Bell, D; McDermott, BJ | 1 |
| Balakumar, P; Rose, M; Singh, M | 1 |
| Berger, JP; Chang, CH; Doebber, TW; McCann, ME; McNamara, LA; Meinke, PT; Muise, ES; Tan, Y; Thompson, JR; Wood, HB; Wu, MS | 1 |
| Asakawa, M; Hasegawa, H; Kadowaki, T; Komuro, I; Kubota, N; Masuda, Y; Nagai, T; Saito, T; Takano, H; Uozumi, H | 1 |
18 other study(ies) available for rosiglitazone and Cardiomegaly
| Article | Year |
|---|---|
Activation of the endocannabinoid system mediates cardiac hypertrophy induced by rosiglitazone.
Topics: Animals; Cardiomegaly; Endocannabinoids; Myocytes, Cardiac; PPAR gamma; Rats; Receptor, Cannabinoid, CB1; Rosiglitazone; TOR Serine-Threonine Kinases | 2022 |
Rosiglitazone promotes cardiac hypertrophy and alters chromatin remodeling in isolated cardiomyocytes.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Chromatin Assembly and Disassembly; Epigenesis, Genetic; Female; Fibrinolytic Agents; Gene Expression Regulation; Histones; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2017 |
Metabonomic profiling revealed an alteration in purine nucleotide metabolism associated with cardiac hypertrophy in rats treated with thiazolidinediones.
Topics: 5' Flanking Region; Adenosine Monophosphate; Adenylosuccinate Synthase; Animals; Cardiomegaly; Gene Expression Regulation; Hypoglycemic Agents; Inosine; Male; Metabolomics; Multivariate Analysis; Myocardium; Pioglitazone; PPAR gamma; Rats; Rats, Sprague-Dawley; Response Elements; Ribose-Phosphate Pyrophosphokinase; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2013 |
Diuretics prevent thiazolidinedione-induced cardiac hypertrophy without compromising insulin-sensitizing effects in mice.
Topics: Animals; Cardiac Volume; Cardiomegaly; Diuretics; Extracellular Signal-Regulated MAP Kinases; Furosemide; Gene Expression Regulation; Glucose; Insulin; Lipid Metabolism; Mice; Mice, Inbred C57BL; Pioglitazone; PPAR gamma; Rosiglitazone; Signal Transduction; Spironolactone; Thiazolidinediones; Trichlormethiazide; Ultrasonography | 2014 |
A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone.
Topics: Animals; Cardiomegaly; Diet, High-Fat; Gene Expression Profiling; Gene Expression Regulation; Genome; Male; Mice; Myocardium; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Pioglitazone; PPAR alpha; Receptors, LDL; Rosiglitazone; Systems Biology; Thiazolidinediones; Transcription Factors; Transcriptome | 2014 |
Adipocyte-specific loss of PPAR
Topics: 3T3 Cells; Adipocytes; Animals; Cardiomegaly; Cells, Cultured; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Myocytes, Cardiac; PPAR gamma; Rosiglitazone; Thiazolidinediones; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins | 2016 |
Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway.
Topics: Animals; Animals, Newborn; Calcineurin; Cardiomegaly; Cell Nucleus; Cell Size; Cyclosporine; Endothelin-1; Myocytes, Cardiac; NFATC Transcription Factors; PPAR gamma; Protein Biosynthesis; Protein Transport; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Surface Properties; Thiazolidinediones | 2008 |
Rosiglitazone-induced heart remodelling is associated with enhanced turnover of myofibrillar protein and mTOR activation.
Topics: Animals; Atrial Natriuretic Factor; Blotting, Western; Body Weight; Cardiomegaly; Eating; Echocardiography; Glucosyltransferases; Glycogen; Glycogen Phosphorylase; Glycogen Synthase; Glycoproteins; Hemodynamics; Hypoglycemic Agents; Lipoprotein Lipase; Male; Myofibrils; Natriuretic Peptide, Brain; Proteasome Endopeptidase Complex; Protein Kinases; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; TOR Serine-Threonine Kinases; UTP-Glucose-1-Phosphate Uridylyltransferase | 2009 |
The inhibitory effects of rosiglitazone on cardiac hypertrophy through modulating the renin-angiotensin system in diet-induced hypercholesterolemic rats.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Cardiomegaly; Cholesterol, Dietary; Hypercholesterolemia; Irbesartan; Male; Myocardium; PPAR gamma; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Rosiglitazone; Tetrazoles; Thiazolidinediones | 2010 |
Effects of metformin on rosiglitazone-induced cardiac hypertrophy in mice.
Topics: Animals; Body Weight; Cardiomegaly; Drug Therapy, Combination; Eating; Male; Metformin; Mice; Mice, Inbred BALB C; Obesity; Rosiglitazone; Thiazolidinediones; Weight Gain | 2010 |
Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Epoxide Hydrolases; Gene Expression Regulation, Enzymologic; Humans; Ligands; Male; Mice; Mice, Knockout; Myocytes, Cardiac; PPAR gamma; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Vasodilator Agents | 2011 |
Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats.
Topics: Albuminuria; Animals; Blood Pressure; Cardiomegaly; Epoxide Hydrolases; Hypertension; Hypoglycemic Agents; Kidney Glomerulus; Macrophages; Male; Obesity; PPAR gamma; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rosiglitazone; Species Specificity; Syndrome; Thiazolidinediones | 2012 |
Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
Topics: Animals; Blood Pressure; Body Weight; Cardiomegaly; Collagen; Desoxycorticosterone; Endothelin-1; Endothelins; Fenofibrate; Fibrosis; Heart; Heart Ventricles; Hypertension; Myocardium; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Ventricular Remodeling | 2003 |
Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Male; MAP Kinase Signaling System; Mice; Mice, Knockout; Myocytes, Cardiac; Myosin Heavy Chains; NF-kappa B; Phosphorylation; PPAR gamma; Rosiglitazone; Systole; Thiazolidinediones | 2005 |
SB-271258, a major metabolite in the dog of the thiazolidinedione, rosiglitazone, stimulates protein synthesis in re-differentiated rat cardiomyocytes in vitro.
Topics: Animals; Cardiomegaly; Cell Differentiation; Cells, Cultured; DNA; Hypoglycemic Agents; Insulin-Like Growth Factor I; Male; Myocytes, Cardiac; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2006 |
Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
Topics: Analysis of Variance; Animals; Aorta, Abdominal; Blood Pressure; Cardiomegaly; Collagen; Constriction, Pathologic; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fenofibrate; Hypoglycemic Agents; Male; Myocardium; Myocytes, Cardiac; Organ Size; PPAR alpha; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Ventricular Function, Left | 2007 |
A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Topics: 3T3-L1 Cells; Acetates; Adipose Tissue, White; Animals; Cardiomegaly; Cardiovascular Diseases; Chlorocebus aethiops; COS Cells; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Partial Agonism; Gene Expression Profiling; Gene Expression Regulation; Hemodilution; Humans; Hypoglycemic Agents; Indoles; Insulin Resistance; Male; Mice; Mice, Inbred Strains; PPAR alpha; PPAR delta; PPAR gamma; Propionates; Protein Binding; Rats; Rats, Zucker; Rosiglitazone; Thiazolidinediones; Transcriptional Activation; Transfection; Water-Electrolyte Balance | 2008 |
Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.
Topics: Actins; Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Cell Size; Cells, Cultured; Chromans; Disease Models, Animal; Gene Expression; Heart; Heterozygote; Hypoglycemic Agents; Ligands; Mice; Mice, Knockout; Myocardium; Organ Size; Pioglitazone; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2002 |